Abeona Therapeutics (ABEO) Share-based Compensation (2010 - 2026)

Abeona Therapeutics' Share-based Compensation history runs 16 years deep, the most recent figure standing at $1.0 million for Q1 2026.

• In Q1 2026, Share-based Compensation fell 62.98% year-over-year to $1.0 million; the TTM figure through Mar 2026 stood at $1.0 million (down 87.15% YoY), while the FY2025 annual figure was $13.7 million, up 106.7% from the prior year.
• Share-based Compensation for Q1 2026 stood at $1.0 million, down from $5.5 million in the prior quarter.
• The five-year high for Share-based Compensation was $5.5 million in Q4 2025, with the low at -$2.8 million in Q4 2023.
• The 5-year median for Share-based Compensation is $1.3 million (2024), against an average of $1.5 million.
• The sharpest annual moves came in 2023 and 2025: Share-based Compensation sank 440.34% in 2023, then jumped 180.31% in 2025.
• Abeona Therapeutics' Share-based Compensation stood at $833000.0 in 2022, then tumbled by 440.34% to -$2.8 million in 2023, then surged by 168.96% to $2.0 million in 2024, then surged by 180.31% to $5.5 million in 2025, then plunged by 81.75% to $1.0 million in 2026.
• Business Quant data shows ABEO's Share-based Compensation at $1.0 million in Q1 2026, $5.5 million in Q4 2025, and $2.7 million in Q3 2025.